Literature DB >> 23889099

Response of Australian veterinarians to the announcement of a Hendra virus vaccine becoming available.

D Mendez1, P Büttner, R Speare.   

Abstract

DESIGN: A cross-sectional study of private veterinarians providing equine services in Queensland.
RESULTS: The study revealed that a majority of veterinarians would support the introduction of a Hendra virus (HeV) vaccine. Moreover, almost half of the respondents intended to make vaccination a prerequisite to horse patient presentation. However, participants also responded that a vaccine would not reduce the risk sufficiently to cease or downgrade their HeV management plan and infection control measures.
CONCLUSION: When devising promoting and marketing campaigns, government agencies and manufacturers should consider private veterinarians' intentions as a significant driver for the uptake of the HeV vaccine.
© 2013 Australian Veterinary Association.

Entities:  

Keywords:  Hendra virus; biosecurity; infection control; vaccines; veterinarians

Mesh:

Substances:

Year:  2013        PMID: 23889099     DOI: 10.1111/avj.12092

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  6 in total

1.  Rhabdovirus-based vaccine platforms against henipaviruses.

Authors:  Drishya Kurup; Christoph Wirblich; Heinz Feldmann; Andrea Marzi; Matthias J Schnell
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

2.  Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody.

Authors:  Thomas W Geisbert; Chad E Mire; Joan B Geisbert; Yee-Peng Chan; Krystle N Agans; Friederike Feldmann; Karla A Fenton; Zhongyu Zhu; Dimiter S Dimitrov; Dana P Scott; Katharine N Bossart; Heinz Feldmann; Christopher C Broder
Journal:  Sci Transl Med       Date:  2014-06-25       Impact factor: 17.956

3.  Henipavirus microsphere immuno-assays for detection of antibodies against Hendra virus.

Authors:  Leanne McNabb; J Barr; G Crameri; S Juzva; S Riddell; A Colling; V Boyd; C Broder; L-F Wang; R Lunt
Journal:  J Virol Methods       Date:  2014-02-05       Impact factor: 2.014

4.  Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.

Authors:  Chad E Mire; Krista M Versteeg; Robert W Cross; Krystle N Agans; Karla A Fenton; Michael A Whitt; Thomas W Geisbert
Journal:  Virol J       Date:  2013-12-13       Impact factor: 4.099

5.  The imperative to develop a human vaccine for the Hendra virus in Australia.

Authors:  Bilal A Zahoor; Lucy I Mudie
Journal:  Infect Ecol Epidemiol       Date:  2015-10-29

6.  Hendra virus in Queensland, Australia, during the winter of 2011: veterinarians on the path to better management strategies.

Authors:  Diana Mendez; Petra Buttner; Rick Speare
Journal:  Prev Vet Med       Date:  2014-08-19       Impact factor: 2.670

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.